Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2410575Generated: November 2, 2026

Tert-butyl[{3-[amino(hydroxyimino)methyl]benzyl}(methyl)amino]acetate → Tert-butyl N-(3-{5-[4-(2-ethylpiperidin-1-yl)-3-(methoxymethyl)phenyl]-1,2,4-oxadiazol-3-yl}benzyl)-N-methylglycinate

https://huagongshe.com/reaction/2410575

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTert-butyl[{3-[amino(hydroxyimino)methyl]benzyl}(methyl)amino]acetateHCID 72307500—
Reactant4-(2-Ethylpiperidin-1-yl)-3-(methoxymethyl)benzoic acid hydrochlorideHCID 131731430—
ProductTert-butyl N-(3-{5-[4-(2-ethylpiperidin-1-yl)-3-(methoxymethyl)phenyl]-1,2,4-oxadiazol-3-yl}benzyl)-N-methylglycinateHCID 66678588—
ProductN-(3-{5-[4-(2-ethylpiperidin-1-yl)-3-(methoxymethyl)phenyl]-1,2,4-oxadiazol-3-yl}benzyl)-N-methylglycine, hydrochloride saltHCID 131731799—

Reaction Steps

Tert-butyl N-(3-{5-[4-(2-ethylpiperidin-1-yl)-3-(methoxymethyl)phenyl]-1,2,4-oxadiazol-3-yl}benzyl)-N-methylglycinate was prepared following the general procedure 3 starting from Intermediate 9 and Intermediate 21. It was hydrolyzed following general procedure 8 to afford the title compound as a white powder. LC/MS (Method B): 479.4 (M+H)+, 477.4 (M−H)−. HPLC (Method A) Rt 2.74 min (Purity: 98.5%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08815919B2
Source datasetuspto-grants-2014_08
ORD IDord-7f43d250d0b64240895bdccec3c07e44
Source noteuspto-grants-2014_08